Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Abeona Therapeutics Inc. ABEO
$3.01
+$0.04 (1.18%)
На 18:00, 12 мая 2023
+99.34%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
53136380.00000000
-
week52high
6.13
-
week52low
2.19
-
Revenue
1414000
-
P/E TTM
0
-
Beta
1.26332100
-
EPS
-5.60000000
-
Last Dividend
3706.25000000
-
Next Earnings Date
11 мая 2023 г. в 11:30
Описание компании
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
SVB Leerink | Market Perform | Market Perform | 11 авг 2022 г. |
SVB Leerink | Market Perform | Outperform | 30 ноя 2021 г. |
HC Wainwright & Co. | Buy | Buy | 29 ноя 2021 г. |
HC Wainwright & Co. | Buy | Buy | 19 июл 2021 г. |
HC Wainwright & Co. | Buy | Buy | 25 ноя 2020 г. |
SVB Leerink | Market Perform | Market Perform | 14 ноя 2022 г. |
Cantor Fitzgerald | Overweight | Overweight | 08 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
O'Malley Brendan M. | A | 93830 | 5869 | 09 дек 2022 г. |
O'Malley Brendan M. | A | 87961 | 7500 | 18 ноя 2022 г. |
Vazzano Joseph Walter | A | 95250 | 2500 | 18 ноя 2022 г. |
Seshadri Vishwas | D | 165732 | 207 | 17 окт 2022 г. |
Vazzano Joseph Walter | A | 92750 | 72750 | 28 сент 2022 г. |
Seshadri Vishwas | A | 165939 | 155200 | 28 сент 2022 г. |
O'Malley Brendan M. | A | 80461 | 72750 | 28 сент 2022 г. |
Charles Faith L. | A | 20414 | 13400 | 26 сент 2022 г. |
Wider Todd | A | 16907 | 13400 | 26 сент 2022 г. |
Amoroso Michael | A | 57711 | 13400 | 26 сент 2022 г. |
Новостная лента
Three Small-Cap Biotech Stocks to Consider Now
MarketBeat
12 дек 2022 г. в 13:58
This article looks at three small-cap biotech companies with stock prices that are making significant moves and have a bright outlook for 2023
PXMD, GETY: The Top 5 Short Squeeze Stocks to Watch This Week
InvestorPlace
21 ноя 2022 г. в 12:49
We're checking in on the top short squeeze stocks to watch this week as traders continue to have an interest in this part of the market! Short squeeze stocks are often subject to volatility with massive gains.
5 Penny Stocks To Buy According To Analysts, Targets Up To 995%
PennyStocks
08 ноя 2022 г. в 14:21
Analysts say these are penny stocks to buy. Do you agree?
Abeona: Pivotal Data Readout EB-101 Before Year End Could Boost Shareholder Value
Seeking Alpha
19 окт 2022 г. в 10:10
Results from the pivotal VITAL study, using EB-101 for the treatment of patients with RDEB are expected to be released before the end of 2022. Should EB-101 be approved by FDA for RDEB, it would give company a Priority Review Voucher, which could be sold for around $100 million or more to another pharmaceutical company.
Best Penny Stocks To Buy? 3 To Watch During The Stock Market Crash
PennyStocks
10 окт 2022 г. в 14:16
Biotech penny stocks for your watch list this week. The post Best Penny Stocks To Buy?